Leap Therapeutics (LPTX) Earnings Date, Estimates & Call Transcripts $0.29 +0.01 (+2.12%) Closing price 04:00 PM EasternExtended Trading$0.29 0.00 (-0.85%) As of 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Leap Therapeutics Earnings Summary Leap Therapeutics announced Q2 2025 earnings on August 14, 2025, reporting an EPS of -$0.40, which missed analysts' consensus estimates of -$0.29 by $0.11. With a trailing EPS of -$1.58, Leap Therapeutics' earnings are expected to grow next year, from ($1.84) to ($1.36) per share. Upcoming Q3 Earnings DateNov. 12Before Market OpensEstimatedConsensus EPS (Aug. 14) -$0.29 Actual EPS (Aug. 14) -$0.40 Missed By -$0.11 Q2 2025 Earnings ResourcesQ2 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)LPTX Upcoming EarningsLeap Therapeutics' next earnings date is estimated for Wednesday, November 12, 2025, based on past reporting schedules. Powered by Get Leap Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Leap Therapeutics and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataLPTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Leap Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.38-$0.38-$0.38Q2 20251-$0.29-$0.29-$0.29Q3 20251-$0.24-$0.24-$0.24Q4 20251-$0.20-$0.20-$0.20 FY 2025 4 -$1.11 -$1.11 -$1.11 Q1 20261-$0.12-$0.12-$0.12Q2 20261-$0.12-$0.12-$0.12Q3 20261-$0.13-$0.13-$0.13Q4 20261-$0.15-$0.15-$0.15 Leap Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/12/2025(Estimated)--------8/14/2025Q2 2025-$0.29-$0.40 -$0.11-$0.40--5/13/2025Q1 2025-$0.38-$0.37+$0.01-$0.37--3/26/2025Q4 2024-$0.39-$0.37+$0.02-$0.37--8/12/2024Q2 2024-$0.42-$0.52 -$0.10-$0.52--5/13/2024Q1 2024-$0.57-$0.51+$0.06-$0.51--3/18/2024Q4 2023-$0.56-$0.46+$0.10-$0.46--11/13/2023Q3 2023-$0.58-$0.51+$0.07-$0.51-- Leap Therapeutics Earnings - Frequently Asked Questions When is Leap Therapeutics' earnings date? Leap Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 12th, 2025 based off last year's report dates. Learn more on LPTX's earnings history. Did Leap Therapeutics beat their earnings estimates last quarter? In the previous quarter, Leap Therapeutics (NASDAQ:LPTX) missed the analysts' consensus estimate of ($0.29) by $0.11 with a reported earnings per share (EPS) of ($0.40). Learn more on analysts' earnings estimate vs. LPTX's actual earnings. How much profit does Leap Therapeutics generate each year? Leap Therapeutics (NASDAQ:LPTX) has a recorded net income of -$67.56 million. LPTX has generated -$1.58 earnings per share over the last four quarters. What is Leap Therapeutics' EPS forecast for next year? Leap Therapeutics' earnings are expected to grow from ($1.84) per share to ($1.36) per share in the next year. More Earnings Resources from MarketBeat Related Companies Precision BioSciences Earnings Date Lantern Pharma Earnings Date Barinthus Biotherapeutics Earnings Date Jasper Therapeutics Earnings Date Kalaris Therapeutics Earnings Date Telomir Pharmaceuticals Earnings Date Century Therapeutics Earnings Date Annovis Bio Earnings Date Shattuck Labs Earnings Date Klotho Neurosciences Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles What to Watch for From D-Wave Now That Earnings Are DoneDICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy?NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive Earnings This page (NASDAQ:LPTX) was last updated on 9/2/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredDid you spot this in the Oval Office last week?When Tim Cook stood in the Oval Office last week, all eyes were on the "unique 24K gold gift" he presented to ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Leap Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Leap Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LPTX Stock Alerts